Basic Information
Basic information for LINC00343-250-23aa
Peptide Name LINC00343-250-23aa
Genome Position chr13:105761440-105761508[+]
Species Human
Peptide Sequence MQFAIKKNAHYGLNVYVLLKFIC
Peptide Length 23
Unique No (LINC00343-203-23aa-1,LINC00343-205-23aa,LINC00343-222-23aa,LINC00343-230-23aa,LINC00343-232-23aa,LINC00343-233-23aa,LINC00343-237-23aa,LINC00343-239-23aa,LINC00343-240-23aa,LINC00343-244-23aa,LINC00343-248-23aa,LINC00343-255-23aa,LINC00343-257-23aa,LINC00343-263-23aa,LINC00343-273-23aa,LINC00343-275-23aa,LINC00343-281-23aa,LINC00343-284-23aa,LINC00343-293-23aa,LINC00343-296-23aa,LINC00343-297-23aa,LINC00343-302-23aa,LINC00343-306-23aa,LINC00343-307-23aa,LINC00343-318-23aa,LINC00343-320-23aa,LINC00343-326-23aa,LINC00343-328-23aa)
Grand Average of Hydropathicity 0.6087
Relative Molecular Mass 3110.65
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000659909;LINC00343-250
Transcript Length 1532
Coding Ability 0.5698
DNA Sequence Corresponding to Peptide ATGCAATTTGCTATAAAGAAGAATGCCCATTACGGACTAAATGTTTATGTCCTCCTAAAATTCATATGT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :